NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye

Completed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye

In brief

Study is to assess the safety and efficacy of NOVA22007 0.05% and 0.1% Cyclosporine Ophthalmic Cationic Emulsions QD compared to vehicle for the treatment of the signs and symptoms of dry eye after a 3 month treatment period.

Key facts

Study ID

NCT00739349

Run by

Santen SAS

People needed

132

Starts

2008-08-01

Expected to finish

2009-01-01

Last updated by the study team

2016-06-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female 18 years and older
• Diagnosis of dry eye in both eyes

You may not qualify if…

• Contraindications to the use of the study medications
• Known allergy or sensitivity to the study medications or their components
• Female currently pregnant, nursing, or planning a pregnancy; or woman who has a positive pregnancy test
• Have participated in an investigational drug or device study within 30 days of Visit 1

Where it is running

• Central Maine Eye Care, PA — Lewiston, Maine, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.